Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 30 citing articles:

Reproducible generation of human liver organoids (HLOs) on a pillar plate platform via microarray 3D bioprinting
Sunil Shrestha, L. Vinod Kumar Reddy, Prabha Acharya, et al.
Lab on a Chip (2024) Vol. 24, Iss. 10, pp. 2747-2761
Open Access | Times Cited: 14
Antitumor Activity of s-Triazine Derivatives: A Systematic Review
Qiuzi Dai, Qinsheng Sun, Xiaorong Ouyang, et al.
Molecules (2023) Vol. 28, Iss. 11, pp. 4278-4278
Open Access | Times Cited: 24
Recent biological applications of heterocyclic hybrids containing s-triazine scaffold
Muhammad Imran Ali, Muhammad Moazzam Naseer
RSC Advances (2023) Vol. 13, Iss. 43, pp. 30462-30490
Open Access | Times Cited: 19
Enhanced Protection of Carbon Steel Against Acid Corrosion: Synergistic Effect of s‐Triazine‐Anilino‐Morpholino‐Pyrazolyl Hybrids Through Electrochemical and Computational Insights
Ihab Shawish, Hassan H. Hammud, Waleed A. Aljamhi, et al.
ChemElectroChem (2025)
Open Access
Combination therapy and dual-target inhibitors based on cyclin-dependent kinases (CDKs): Emerging strategies for cancer therapy
Qi Hao, Wenzhe Zhao, Zhijia Li, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117465-117465
Closed Access
Development of certain benzylidene coumarin derivatives as anti-prostate cancer agents targeting EGFR and PI3Kβ kinases
Lina M. A. Abdel Ghany, Tarek S. Ibrahim, Abdulrahman S. Alharbi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 4
Bis(dimethylpyrazolyl)-aniline- s -triazine derivatives as efficient corrosion inhibitors for C-steel and computational studies
Hassan H. Hammud, Nadeem S. Sheikh, Ihab Shawish, et al.
Royal Society Open Science (2024) Vol. 11, Iss. 5
Open Access | Times Cited: 4
Acetic Acid Mediated for One-Pot Synthesis of Novel Pyrazolyl s-Triazine Derivatives for the Targeted Therapy of Triple-Negative Breast Tumor Cells (MDA-MB-231) via EGFR/PI3K/AKT/mTOR Signaling Cascades
Ihab Shawish, Assem Barakat, Ali Aldalbahi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1558-1558
Open Access | Times Cited: 19
Identification of indole-grafted pyrazolopyrimidine and pyrazolopyridine derivatives as new anti-cancer agents: Synthesis, biological assessments, and molecular modeling insights
Wagdy M. Eldehna, Haytham O. Tawfik, Maha-Hamadien Abdulla, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107804-107804
Closed Access | Times Cited: 3
Reproducible generation of human liver organoids (HLOs) on a pillar plate platformviamicroarray 3D bioprinting
Sunil Shrestha, L. Vinod Kumar Reddy, Prabha Acharya, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
Experimental and Computational Anticorrosion Behaviors of Pyrazole s-Triazine/anilino-morpholino Derivatives for Steel in Acidic Solutions
Hassan H. Hammud, Waleed A. Aljamhi, Ihab Shawish, et al.
ACS Omega (2024) Vol. 9, Iss. 29, pp. 31714-31731
Open Access | Times Cited: 2
1,3,5-Triazine as a promising scaffold in the development of therapeutic agents against breast cancer
Han Yin Lim, Anton V. Dolzhenko
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116680-116680
Open Access | Times Cited: 2
Design, synthesis, anticancer evaluation and molecular docking studies of 1,2,3-triazole incorporated 1,3,4-oxadiazole-Triazine derivatives
Sujana Oggu, Parameswari Akshinthala, Naresh Kumar Katari, et al.
Heliyon (2023) Vol. 9, Iss. 5, pp. e15935-e15935
Open Access | Times Cited: 7
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets
Alia Mushtaq, Peng Wu, Muhammad Moazzam Naseer
Pharmacology & Therapeutics (2023) Vol. 254, pp. 108579-108579
Closed Access | Times Cited: 7
Pyrazolyl-s-triazine with indole motif as a novel of epidermal growth factor receptor/cyclin-dependent kinase 2 dual inhibitors
Ihab Shawish, Mohamed S. Nafie, Assem Barakat, et al.
Frontiers in Chemistry (2022) Vol. 10
Open Access | Times Cited: 11
Design, Synthesis, Docking Studies and Molecular Dynamics Simulation of New 1,3,5‐Triazine Derivatives as Anticancer Agents Selectively Targeting Pancreatic Adenocarcinoma (Capan‐1)
Shazia Asghar, Shahid Hameed, Najim A. Al‐Masoudi, et al.
Chemistry & Biodiversity (2024) Vol. 21, Iss. 5
Closed Access | Times Cited: 1
Novel Cu(II) and Zn(II) Nanocomplexes Based on 5,6‐Diphenyl‐1,2,4‐Triazine: Preparation, Spectroscopic, TD‐DFT Calculations, Molecular Docking and Solvatochromic Studies
Mona Boshra, Omima M.I. Adly, Ebtesam M. Abdelrhman, et al.
Applied Organometallic Chemistry (2024)
Closed Access | Times Cited: 1
Synthetic and pharmacological developments in the hybrid s-triazine moiety: A review
Diksha Bareth, Sonika Jain, Jyoti Kumawat, et al.
Bioorganic Chemistry (2023) Vol. 143, pp. 106971-106971
Closed Access | Times Cited: 4
Synthesis and Characterizations of Novel Isatin-s-Triazine Hydrazone Derivatives; X-ray Structure, Hirshfeld Analysis and DFT Calculations
Hessa H. Al‐Rasheed, Sarah A. AL-khamis, Assem Barakat, et al.
Crystals (2023) Vol. 13, Iss. 2, pp. 305-305
Open Access | Times Cited: 3
Synthesis, Structure and Antimicrobial Activity of New Co(II) Complex with bis-Morpholino/Benzoimidazole-s-Triazine Ligand
Saied M. Soliman, Eman M. Fathalla, Mona M. Sharaf, et al.
Inorganics (2023) Vol. 11, Iss. 7, pp. 278-278
Open Access | Times Cited: 3
Stearyl palmitate a multi-target inhibitor against breast cancer: in-silico, in-vitro & in-vivo approach
Lokesh Ravi, Ajith Kumar K, Shree Kumari G R, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 42, Iss. 19, pp. 10057-10074
Closed Access | Times Cited: 2
Cytotoxicity and Apoptosis-Induction in MCF-7 Cells for New Pd(II) Complex Based on s-Triazine Ligand: Synthesis, Single Crystal X-ray Diffraction Analysis and Structural Investigations
Abdulmajeed Abdullah Alayyaf, Assem Barakat, Abdullah Mohammed Al‐Majid, et al.
Crystals (2023) Vol. 13, Iss. 10, pp. 1472-1472
Open Access | Times Cited: 2
New thiazolo-quinolone hybrids as EGFR and/or PI3K inhibitors and as apoptosis inducers via modulating Bax/Bcl-2/p53 cascade
Asmaa H. Mohamed, Ashraf A. Aly, Mohammed B. Alshammari, et al.
Monatshefte für Chemie - Chemical Monthly (2024) Vol. 155, Iss. 11, pp. 1131-1143
Closed Access
Exploring the Anticancer Potential of Triazine Derivatives: An Outlook of Designing Strategies, Docking Studies, and Structure‐Activity Relationships (SAR)
B V Manjushree, Gurubasavaraja Swamy Purawarga Matada, Rohit Pal, et al.
ChemistrySelect (2024) Vol. 9, Iss. 41
Open Access
A New Bromo-Mn(II) Complex with 1,3,5-Triazine Derivative: Synthesis, Crystal Structure, DFT and Biological Studies
Sara M. Khattab, Mezna Saleh Altowyan, Ayman El‐Faham, et al.
Inorganics (2024) Vol. 12, Iss. 11, pp. 284-284
Open Access
Page 1 - Next Page

Scroll to top